ArticlePloS one2017

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.

Nicola Gianotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.